Teva Launches First Generic GLP-1 Weight-Loss Drug After FDA Approval
The FDA approved Teva Pharmaceutical's generic version of Saxenda, a weight-loss drug by Novo Nordisk, marking the first generic GLP-1 product for weight loss, potentially offering a lower-cost alternative and impacting Novo Nordisk's sales.